Advertisement

Polymorphe lichtdermatose: Was hilft wirklich?

Conference paper
Part of the Fortschritte der praktischen Dermatologie und Venerologie book series (DERMATOLOGIE, volume 17)

Zusammenfassung

Die polymorphe Lichtdermatose (PLD) ist mit 90 % aller lichtinduzierten Hauterkrankungen die häufigste Photo dermatose. Die Angaben über die Prävalenz sind nicht einheitlich und schwanken zwischen 10 - 20 %. Frauen sind deutlich häufiger betroffen als Männer.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Addo H.A., Sharma S.C. (1987) UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphie light eruption and solar urtiearia. Br J Dermatol 116:539–547PubMedCrossRefGoogle Scholar
  2. 2.
    Becker S.W. (1959) Prevention of sunburn and light allergy with methoxalen. Gener Practitioner 19: 115–117Google Scholar
  3. 3.
    Brehm G., Bröcker E.B., Elsner P., Jung E.G., Zaun H. (1998) UV-B induzierte polymorphe Liehtdermatose: Protektion durch topische Antioxidantien. Aktuelle Dermatol 24: 11–14Google Scholar
  4. 4.
    Cahn M.M., Levy E.J., Shaffer B. (1959) Experimentally induced reactions to ultraviolet light. I. Polymorphous light eruption and phototoxeiity to drugs. J Invest Dermatol 32: 355–361PubMedCrossRefGoogle Scholar
  5. 5.
    Christiansen J.V., Brodthagen H. (1956) The treatment of polymorphous light eruption with chloroquine. Br J Dermatol 68: 204–208PubMedCrossRefGoogle Scholar
  6. 6.
    Corbett M.F., Hawk J.L., Herxheimer A., Magnus I.A. (1982) Controlled therapeutie trials in polymorphous light eruption. Br J Dermatol 107: 571–581PubMedCrossRefGoogle Scholar
  7. 7.
    Diepgen T.L., Häberle M., Fartasch M., Stüben O., Hornstein O.P. (1989) Charakteristika der polymorphen Liehtdermatose: Ergebnis einer prospektiven Befragung und Untersuchung 302 Betroffener. Z Hautkr 64: 279–285PubMedGoogle Scholar
  8. 8.
    Grether-Beck S., Olaizola-Horn S., Schmitt H., Grewe M., Jahnke A., Johnson J., Briviba K., Sies H., Krutmann J. (1996) Activation of transcription factor AP-2 mediates UVA radiation and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci USA 93: 1–6CrossRefGoogle Scholar
  9. 9.
    Gschnait F., Schwarz T., Ladich I. (1983) Treatment of polymorphous light eruption. Arch Dermatol Res 275: 379–382PubMedCrossRefGoogle Scholar
  10. 10.
    Häberle M., Arnold M., Koch H.U., Grühn E., Hornstein O.P. (1991) Nikotinsäureamid zur Prophylaxe der polymorphen Lichtdermatose PLD-eine plazebokontrollierte Doppelblindstudie. Vita Min Spur 6: 29–37Google Scholar
  11. 11.
    Hadshiew I., Stäb F., Untiedt S., Bohnsack K., Rippke F., Hölzle E. (1997) Effects oftopically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology 195: 362–368PubMedCrossRefGoogle Scholar
  12. 12.
    Hölzle E., Lehmann P. (1999) Polymorphous light eruption. In: Demis D.J. (ed) Clinical dermatology. Lippincott Williams & Wilkins 19-3: 1–9Google Scholar
  13. 13.
    Hölzle E., Plewig G., Hofmann C., Roser-Maas E. (1982) Polymorphous light eruption. Experimental reproduction of skin lesions. J Am Acad Dermatol 7: 111–125PubMedCrossRefGoogle Scholar
  14. 14.
    Hölzle E., Plewig G., Kries R., Lehmann P. (1987) Polymorphous light eruption. J Invest Dermatol 88: 32–38CrossRefGoogle Scholar
  15. 15.
    Hönigsmann H. (1989) Wirkung einer therapeutischen Liehtschutzcreme auf die Phototestreaktion bei polymorpher Liehtdermatose. Z Hautkr 64: 1065–1068PubMedGoogle Scholar
  16. 16.
    Hönigsmann H., Ortel B. (1988) Die polymorphe Lichtdermatose-Photo biologische Diagnostik und Therapie. Z Hautkr 63: 676–678PubMedGoogle Scholar
  17. 17.
    Husain S.R., Cillard J., Cillard P. (1987) Hydroxyl radical scavenger activity of flavinoids. Phytochemistry 26: 2489–2491CrossRefGoogle Scholar
  18. 18.
    Ippen H., Kölmel K. (1980) Lichtschutz gegen Ultraviolett A. Ärztl Kosmetol 10: 219–226Google Scholar
  19. 19.
    Jansen C.T. (1974) Beta-carotene treatment of polymorphous light eruption. Dermatologiea 149: 363–373CrossRefGoogle Scholar
  20. 20.
    Jansen C.T. (1985) Oral carotinoid treatment in polymorphous light eruption: a cross-over comparison with oxychloroquine and placebo. Photodermatology 2: 166–169PubMedGoogle Scholar
  21. 21.
    Jansen C.T., Karvonen J., Malmiharju T. (1982) PUVA therapy for polymorphous light eruptions: comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanisms. Acta Derm Venereol 62: 317–320PubMedGoogle Scholar
  22. 22.
    Krutmann J., Grewe M. (1995) Involvement of cytokines, DNA damage and reactive oxygen intermediates in ultraviolet radiation induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 105: 67–70CrossRefGoogle Scholar
  23. 23.
    Kuhn A., Richter-Hintz D., Oslislo C., Ruzieka T., Megahed M., Lehmann P. (2000) Lupus erythematosus tumidus. A neglected sub set of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 136: 1033–1041PubMedCrossRefGoogle Scholar
  24. 24.
    Lehmann P. (1996) Photosensitivität des Lupus erythematodes. Aktuelle Dermatol 22: 47–51Google Scholar
  25. 25.
    Lehmann P., Hölzle E., Kind P., Goerz G., Plewig G. (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Dermatol 22:181–187CrossRefGoogle Scholar
  26. 26.
    Lovell C.R., Hawk J.C.M., Calnan C.D., Magnus I.A. (1983) Thalidomide in actinie prurigo. Br J Dermatol 108: 467–471PubMedCrossRefGoogle Scholar
  27. 27.
    Mathews-Roth M.M., Pathak M.A., Fitzpatriek T.B., Harber L.C., Kass E.M. (1977) Beta-carotene therapy for erythropoetic protoporphyria and other photosensitivity diseases. Arch Dermatol 113: 1229–1232PubMedCrossRefGoogle Scholar
  28. 28.
    Mattheus A., Rader C., Heise H. (1988) Nicotinsäureamid bei polymorphen Liehtdermatosen. Dermatol Monatschr 174: 142–146Google Scholar
  29. 29.
    McFadden N. (1984) UVA sensitivity and topieal photoprotection in polymorphous light eruption. Photodermatology 1: 76–78PubMedGoogle Scholar
  30. 30.
    Meffert H., Sönniehsen N. (1984) Photokonditionierung bei polymorpher Lichtdermatose. Dermatol Monatsschr 170: 274–276PubMedGoogle Scholar
  31. 31.
    Molin L., Volden G. (1987) Treatment of polymorphous light eruption with PUVA and prednisolone. Photodermatology 4: 107–108PubMedGoogle Scholar
  32. 32.
    Morison W.L., Momtaz K., Mosher D.B., Parrish J.A. (1982) UV-B phototherapy and prophylaxis of polymorphous light eruption. Br J Dermatol 106: 231–233PubMedCrossRefGoogle Scholar
  33. 33.
    Murphy G.M., Hawk J.L.M., Magnus I.A. (1987) Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 116:379–386PubMedCrossRefGoogle Scholar
  34. 34.
    Murphy G.M., Logan R.A., Lovell C.R., Morris R.W., Hawk J.L.M., Magnus I.A. (1987) Prophylactic PUVA and UVB therapy in polymorphic light eruption-a controlled trial. Br J Dermatol 116: 531–538PubMedCrossRefGoogle Scholar
  35. 35.
    Neumann J.R. (1988) Polymorphous light eruption and oral contraceptives. Photodermatology 5: 40–41PubMedGoogle Scholar
  36. 36.
    Neumann N.J., Lehmann P. (2000) Polymorphe Liehtdermatose (PLD). In: Photodermatosen. Ein Leitfaden zur Diagnostik. Steinkopff, DarmstadtCrossRefGoogle Scholar
  37. 37.
    Neumann R., Rappold E. (1985) Therapie der polymorphen Liehtdermatose mit Nieotinamid. Zentralbl Haut Geschlechtskr 150: 628Google Scholar
  38. 38.
    Neumann R., Rappold E., Pohl-Markl H. (1986) Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol 115: 77–80PubMedCrossRefGoogle Scholar
  39. 39.
    Norris P.G., Barker J.N.W.N., Allen M.H., Leifermann K.M., MacDonald D.M., Haskard D.O., Hawk J.L.M. (1992) Adhesion molecule expression in polymorphous light eruption. J Invest Dermatol 99: 504–508PubMedCrossRefGoogle Scholar
  40. 40.
    Norris P.G., Hawk J.L.M. (1989) Successful treatment of severe polymorphous light eruption with azathioprine. Arch Dermatol 125: 1377–1379PubMedCrossRefGoogle Scholar
  41. 41.
    Ortel B., Tanew H., Hönigsmann W., Wolff K. (1986) Polymorphous light eruption. Action spectrum and photoprotection. J Am Acad Dermatol 14: 748–753PubMedCrossRefGoogle Scholar
  42. 42.
    Ortel B., Wechdorn D., Tanew A., Hönigsmann H. (1988) Effect of nicotinamide on the phototest reaction in polymorphous light eruption. Br J Dermatol 118: 669–673PubMedCrossRefGoogle Scholar
  43. 43.
    Parrish J.A., Levin M.J., Morison W.L., Gonzalez E., Fitzpatriek T.B. (1979) Comparison ofPUVA and beta-carotene in the treatment of polymorphous light eruption. Br J Dermatol 100:187–198PubMedCrossRefGoogle Scholar
  44. 44.
    Plewig G., Hölzle E., Lehmann P. (1986) Phototherapy for photodermatoses. In: Höngismann H., Stingl G. (eds) Therapeutie photomedicine. Karger, Basel, pp 254–264CrossRefGoogle Scholar
  45. 45.
    Przybilla B., Heppeler M., Ruzieka T. (1989) Preventive effect of an E. coli filtrate (Colibiogen) in polymorphous light eruption. Br J Dermatol 121: 229–233PubMedCrossRefGoogle Scholar
  46. 46.
    Saul A., Flores O., Novales J. (1976) Polymorphous light eruption: treatment with thalidomide. Australas J Dermatol 17:17–21PubMedCrossRefGoogle Scholar
  47. 47.
    Sippel A. (1996) Klinisch-experimentelle Untersuchungen zur Wirksamkeit einer systemischen Medikation zur Prophylaxe der polymorphen Liehtdermatose. Deutsche Hochschulschr 2321, Hänsel-Hohenhausen, EgelsbachGoogle Scholar
  48. 48.
    Sontheimer R.D., Thomas J.R., Gilliam J.N. (1989) Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115: 1409–1415CrossRefGoogle Scholar
  49. 49.
    Swanbeck G., Wennersten G. (1972) Treatment of polymorphous light eruption with beta-carotene. Acta Derm Venereol 52: 462–466PubMedGoogle Scholar
  50. 50.
    Thune P. (1976) Chronie polymorphie light eruption. Particular wavebands and the effect of carotene therapy. Acta Derm Venereol 56: 127–133PubMedGoogle Scholar
  51. 51.
    Van der Leun J.C., van Weelden H. (1975) Light-induced tolerance to light in photodermatoses. J Invest Dermatol 64:280Google Scholar
  52. 52.
    Woodburne A.R., Philpott O.S., Philpott J.A. (1964) Quinacrine (Atabrine) in treatment of solar dermatoses. Arch Dermatol 70: 116–118CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

There are no affiliations available

Personalised recommendations